The median age was 60 years, the median tumor size was 1.8 cm, 86.1% of the patients had estrogen receptor (ER)-positive cancers, 58.1% of the patients received adjuvant chemotherapy, and 73.8% of the patients received radiation therapy (RT). Here, ESR1 is linked to neoplasm.